Table 3.
Clinical efficacy evaluation of the 2 groups of patients at the last follow-up.
Grouping | Excellent | Good | Middle | Difference | Excellent rate |
---|---|---|---|---|---|
Short-course intensive chemotherapy group (n=53) | 62.26% | 24.53% | 9.43% | 3.77% | 86.79% |
Traditional quadruple chemotherapy group (n=70) | 68.57% | 15.71% | 11.43% | 4.29% | 84.28% |
Comparison of the above 2 groups χ2=0.074, P=0.961.